- SLRN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Acelyrin (SLRN) 8-K20 Mar 24Rapid improvements demonstrated for proptosis, clinical activity scores, and diplopia versus placebo with a favorable safety profileFinancial data
Company Profile